ZNTL 8-K 2026-01-09

Zentalis Pharmaceuticals, Inc. (ZNTL) 8-K dated 2026-01-09 — accession 0001725160-26-000003. This URL is the filing, not the ZNTL hub.

Zentalis Pharmaceuticals, Inc. (ZNTL) is a biotechnology company listed on NASDAQ.

Zentalis Pharmaceuticals, Inc. filed a 8-K on 2026-01-09. Accession 0001725160-26-000003.

Cached items: 7.01, 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.

Not investment advice. The ZNTL SEC hub lists recent forms. The stock page is the research view.